1
|
Simon J, Jouanmiqueou B, Rols MP, Flahaut E, Golzio M. Transdermal Delivery of Macromolecules Using Two-in-One Nanocomposite Device for Skin Electroporation. Pharmaceutics 2021; 13:pharmaceutics13111805. [PMID: 34834220 PMCID: PMC8624044 DOI: 10.3390/pharmaceutics13111805] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2021] [Revised: 10/22/2021] [Accepted: 10/23/2021] [Indexed: 11/27/2022] Open
Abstract
Delivery of hydrophilic molecules through the skin using electroporation is a promising alternative approach to intradermal injection. Recently, we developed a two-in-one electrode/reservoir material composed of carbon nanotubes and agarose hydrogel. In this work, we evaluated the potential of the device to achieve non-invasive transdermal drug delivery using skin electroporation. As it involved an electrode configuration different from the literature, critical questions were raised. First, we demonstrated the efficiency of the device to permeabilize the skin of hairless mice, as observed by propidium iodide (PI) uptake in the nuclei of the epidermis cells through macro fluorescence imaging and histology. Application of Lucifer yellow (LY) at different times after unipolar electroporation treatment demonstrated the partial reversibility of the skin permeabilization after 30 min, and as such, that barrier function properties tended to be restored. We uncovered, for the first time to our knowledge, an intrinsic asymmetry of permeation pathways generated in the stratum corneum during treatment. Electrophoresis was here the main driving force for macromolecule delivery, but it competed with passive diffusion through the generated aqueous pathways for smaller molecules. Finally, we validated 4 kDa dextran labelled with fluorescein isothiocyanate (FD4) as a model molecule to optimize the electrical parameters, needed to improve macromolecule delivery.
Collapse
Affiliation(s)
- Juliette Simon
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Université Toulouse 3—Paul Sabatier, 205 Route de Narbonne, CEDEX 4, 31077 Toulouse, France; (J.S.); (B.J.); (M.-P.R.)
- Centre Interuniversitaire de Recherche et d’Ingénierie des Matériaux, CIRIMAT, Université de Toulouse, CNRS, Université Toulouse 3—Paul Sabatier, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France
| | - Bastien Jouanmiqueou
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Université Toulouse 3—Paul Sabatier, 205 Route de Narbonne, CEDEX 4, 31077 Toulouse, France; (J.S.); (B.J.); (M.-P.R.)
| | - Marie-Pierre Rols
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Université Toulouse 3—Paul Sabatier, 205 Route de Narbonne, CEDEX 4, 31077 Toulouse, France; (J.S.); (B.J.); (M.-P.R.)
| | - Emmanuel Flahaut
- Centre Interuniversitaire de Recherche et d’Ingénierie des Matériaux, CIRIMAT, Université de Toulouse, CNRS, Université Toulouse 3—Paul Sabatier, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France
- Correspondence: (E.F.); (M.G.); Tel.: +33-561-55-6970 (E.F.); +33-561-17-5813 (M.G.)
| | - Muriel Golzio
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Université Toulouse 3—Paul Sabatier, 205 Route de Narbonne, CEDEX 4, 31077 Toulouse, France; (J.S.); (B.J.); (M.-P.R.)
- Correspondence: (E.F.); (M.G.); Tel.: +33-561-55-6970 (E.F.); +33-561-17-5813 (M.G.)
| |
Collapse
|